Commentary

Oncogene (2005) 24, 326–328. doi:10.1038/sj.onc.1208252 Published online 8 November 2004

Ral-GTPases: good chances for a long-lasting fame

Elena Feinstein1

1Quark Biotech Inc., Ness Ziona, Israel

Correspondence: E Feinstein, E-mail: elenaf@qbi.co.il

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

REVIEWS

Immunoregulatory functions of mTOR inhibition

Nature Reviews Immunology Review (01 May 2009)